Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-12-026754

SVP, Preclinical Research acquired 15,938 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Bencherif Merouane · SVP, Preclinical Research

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2012-05-18 Exercise or conversion : show line 1 in the form +15,938 $2.93 $46,698 15,938 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-05-18 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −15,938 $2.93 2019-01-08 15,938 7,970 D
Loading xslF345X03/doc1.xml…